Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care
Award amount
$2,464,035Program and phase
STTR · Phase IIAward year
2024Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PASCALL Systems, Incorporated
- Proposal award date
- 2024-09-01
- Contract end date
- 2026-08-31
- UEI
- PX3XJYHFN4S1
- Solicitation number
- NS20-009
- Topic code
- 106
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Commercialization Readiness of an Intraoperative EEG-Guided Precision Anesthesia Management System to Prevent Postoperative Delirium in Elderly and Patients at Risk for Alzheimer's & Related Dementia
- Developing an Elderly Patient-Specific, Accurate, Intuitive and Highly Interpretable System for Unconsciousness Management in General Anesthesia Using PASCALL FDA-Cleared Intraoperative EEG Monitor
- Developing a novel system combining cognitive assessment with PASCALL FDA-cleared intraoperative anesthesia EEG brain monitor to prevent postoperative neurocognitive disorders in aging patients
- Developing an Intraoperative EEG-Guided Precision Anesthesia Management System to Prevent Postoperative Delirium in Elderly and Patients at Risk for Alzheimer's & Related Dementias
- Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Clinical Validation of Myoelectric Implant for Intuitive Prosthesis Control
- Targeted ColQ gene therapy for Congenital Myasthenic Syndromes
- Further assessment of durability of a gene editing therapy for Duchenne muscular dystrophy
- Developing closed-loop tonic motor activation therapy for treatment of refractory restless legs syndrome
- Engineered microglia for the treatment of Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)
Research funding history
14 SBIR/STTR records share this UEI (2020–2025). Reported award amounts total $17,397,609. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services